Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Choroid plexus tumours
Choroid plexus tumours are rare epithelial brain tumours and limited information is available regarding their biology and the best treatment. A meta-analysis was done to determine prognostic factors… Expand
Postoperative Adjuvant Dendritic Cell–Based Immunotherapy in Patients with Relapsed Glioblastoma Multiforme
- S. De Vleeschouwer, S. Fieuws, +12 authors S. V. van Gool
- Medicine
- Clinical Cancer Research
- 15 May 2008
Purpose: To investigate the therapeutic role of adjuvant vaccination with autologous mature dendritic cells (DC) loaded with tumor lysates derived from autologous, resected glioblastoma multiforme… Expand
Radiation therapy and survival in choroid plexus carcinoma
- J. Wolff, M. Sajedi, M. Coppes, R. A. Anderson, R. Egeler
- Medicine
- The Lancet
- 19 June 1999
Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study
- S. Rutkowski, S. De Vleeschouwer, +10 authors S. V. van Gool
- Medicine
- British Journal of Cancer
- 12 October 2004
Patients with relapsed malignant glioma have a poor prognosis. We developed a strategy of vaccination using autologous mature dendritic cells loaded with autologous tumour homogenate. In total, 12… Expand
Malignant progression in choroid plexus papillomas.
- A. Jeibmann, B. Wrede, O. Peters, J. Wolff, W. Paulus, M. Hasselblatt
- Medicine
- Journal of neurosurgery
- 12 December 2007
OBJECT
Malignant progression of choroid plexus papillomas has been occasionally reported, but this issue has not yet been systematically addressed.
METHODS
Frequency and extent of malignant… Expand
Oral topotecan in children with recurrent or progressive high‐grade glioma
- Sabine Wagner, B. Erdlenbruch, +8 authors J. Wolff
- Medicine
- Cancer
- 15 April 2004
Continuous oral treatment with topotecan may be more effective than the typical 1‐day and 5‐day treatment schedules. In previous studies of continuous treatment with topotecan, increased intestinal… Expand
Preradiation chemotherapy of children and young adults with malignant brain tumors: results of the German pilot trial HIT'88/'89.
- J. Kuehl, H. Müller, +14 authors O. Wiestler
- Medicine
- Klinische Padiatrie
- 1 July 1998
BACKGROUND
Preradiation chemotherapy could be beneficial in malignant brain tumors, because the blood-brain tumor-barrier is disrupted after surgery, bone marrow recovery--essential for intense… Expand
Intensive chemotherapy improves survival in pediatric high‐grade glioma after gross total resection: results of the HIT‐GBM‐C protocol
- J. Wolff, P. H. Driever, +7 authors C. Kramm
- Medicine
- Cancer
- 1 February 2010
The authors hypothesized that intensified chemotherapy in protocol HIT‐GBM‐C would increase survival of pediatric patients with high‐grade glioma (HGG) and diffuse intrinsic pontine glioma (DIPG).
Preradiation chemotherapy for pediatric patients with high‐grade glioma
To evaluate the feasibility and efficacy of intensive chemotherapy given prior to irradiation in pediatric patients with malignant glioma, the Society of Pediatric Oncology in Germany started a… Expand
Transient local response and persistent tumor control in a child with recurrent malignant glioma: treatment with combination therapy including dendritic cell therapy. Case report.
- S. De Vleeschouwer, F. Van Calenbergh, +7 authors S. V. van Gool
- Medicine
- Journal of neurosurgery
- 1 May 2004
Treatment of malignant glioma is difficult and discouraging. Even after resection and maximal adjuvant therapy, the prognosis remains poor. The authors sought a novel form of treatment, such as… Expand